ICD-10-CM Code C81.02

Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes

Version 2021 Billable Code

Valid for Submission

C81.02 is a billable code used to specify a medical diagnosis of nodular lymphocyte predominant hodgkin lymphoma, intrathoracic lymph nodes. The code is valid for the fiscal year 2021 for the submission of HIPAA-covered transactions. The ICD-10-CM code C81.02 might also be used to specify conditions or terms like hodgkin lymphoma, nodular lymphocyte predominance or hodgkin's disease of intrathoracic lymph nodes or hodgkin's paragranuloma of intrathoracic lymph nodes.

ICD-10:C81.02
Short Description:Nodular lymphocy predom Hodgkin lymphoma, intrathorac nodes
Long Description:Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Hodgkin lymphoma, nodular lymphocyte predominance
  • Hodgkin's disease of intrathoracic lymph nodes
  • Hodgkin's paragranuloma of intrathoracic lymph nodes

Diagnostic Related Groups

The ICD-10 code C81.02 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2021.

  • 820 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC
  • 821 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC
  • 822 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC

Convert C81.02 to ICD-9

  • 201.42 - Hodg lymph-histio thorax (Approximate Flag)

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
      • Hodgkin lymphoma (C81)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021

Information for Patients


Hodgkin Disease

Also called: Hodgkin lymphoma

Hodgkin disease is a type of lymphoma. Lymphoma is a cancer of a part of the immune system called the lymph system. The first sign of Hodgkin disease is often an enlarged lymph node. The disease can spread to nearby lymph nodes. Later it may spread to the lungs, liver, or bone marrow. The exact cause is unknown.

Hodgkin disease is rare. Symptoms include

  • Painless swelling of the lymph nodes in the neck, armpits, or groin
  • Fever and chills
  • Night sweats
  • Weight loss
  • Loss of appetite
  • Itchy skin

To diagnose Hodgkin disease, doctors use a physical exam and history, blood tests, and a biopsy. Treatment depends on how far the disease has spread. It often includes radiation therapy or chemotherapy.

The earlier the disease is diagnosed, the more effective the treatment. In most cases, Hodgkin disease can be cured.

NIH: National Cancer Institute

  • Chest radiation - discharge (Medical Encyclopedia)
  • Hodgkin lymphoma (Medical Encyclopedia)
  • Hodgkin lymphoma - children (Medical Encyclopedia)

[Learn More]